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The Wingless/Wnt pathway controls cell fates during
animal development and regulates tissue homeosta-
sis as well as stem cell number and differentiation
in epithelia. Deregulation of Wnt signaling has been
associated with cancer in humans. In the nucleus,
the Wingless/Wnt signal is transmitted via the key ef-
fector protein Armadillo/b-catenin. The recent iden-
tification and functional analysis of novel Armadillo/
b-catenin interaction partners provide new and ex-
citing insights into the highly complex mechanism
of Wingless/Wnt target gene activation.
Signaling molecules of the Wingless (Wg)/Wnt family
are secreted glycoproteins that control a diverse array
of processes in embryos and adult animals. The Wnt
cascade has been implicated in the postembryonic
regulation of stem cell number and differentiation of
several adult stem cell systems [1,2]. Moreover, the
pathway has been causally linked to various diseases,
most notably to cancer [3,4]. In the absence of the
Wg/Wnt signal, DNA-bound transcription factors of
the T-cell factor (TCF) family of HMG-box proteins bind
the transcriptional repressors Groucho (Gro)/TLE and
Carboxy-terminal binding protein (CtBP). Upon activa-
tion of the pathway, the key transducing component
Armadillo (Arm)/b-catenin becomes stabilized, enters
the nucleus and heterodimerizes with TCFs to activate
the expression of Wg/Wnt target genes. This co-acti-
vator function of Arm/b-catenin depends mainly on two
domains or ‘arms’: An amino-terminal activating arm
(NTAA) recruits Legless (Lgs)/B-cell lymphoma 9
(BCL9) and Pygopus (Pygo), while a carboxy-terminal
activating arm (CTAA) binds to TATA-binding protein
(TBP), Brahma/Brahma-related gene-1 (Brg-1), CREB-
binding protein (CBP)/p300, Mediator subunit 12
(MED12), and Hyrax/Parafibromin. Despite its thera-
peutic relevance, the mechanisms by which Arm/
b-catenin employs these co-factors to control the tran-
scription of target genes are only poorly understood.
Here, we review past and recent findings that relate
to this problem and discuss how they can be inte-
grated into a more complete picture of Wg/Wnt target
gene activation.
The Dual Role of Arm/b-catenin
Arm/b-catenin fulfills two main functions in the cell:
First, it acts as a component of the cadherin-based
cell adhesion system. It binds the transmembrane pro-
tein E-cadherin and regulates actin filament assembly
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*E-mail: basler@molbio.unizh.chvia a-catenin [5]. Second, Arm/b-catenin acts as a
nuclear regulator of Wg/Wnt dependent gene ex-
pression and provides transcriptional activator func-
tions to TCFs. The Arm/b-catenin protein consists of
a central region that is made up of 12 imperfect arma-
dillo repeats (R1-12) flanked by an amino- and a
carboxy-terminal tail [6]. There are mutant forms of
Arm that interfere with the adhesion function, but not
with its role in Wg/Wnt signaling, and vice versa, indi-
cating that these two functions of Arm are indepen-
dent and separable [7,8]. Interestingly, the nematode
Caenorhabditis elegans has three different b-catenin
proteins which are dedicated either to adhesion
(HMP-2) or to Wnt signaling (WRM-1 and BAR-1) [9].
In the absence of a Wg/Wnt signal, cytosolic Arm/
b-catenin is constantly phosphorylated by the action
of a so-called ‘degradation complex’ consisting of the
Adenomatous polyposis coli (APC) protein, Axin, and
the kinases Casein kinase I (CKI) and Shaggy/Zeste
white-3/Glycogen synthase kinase-3b (GSK-3b). Phos-
phorylated Arm/b-catenin is rapidly degraded via the
ubiquitin/proteasome pathway [10]. Interaction of the
Wg/Wnt ligand with its receptors Frizzled and Arrow/
LDL-receptor-related protein (LRP) blocks the degra-
dation complex thus leading to stabilization of Arm/
b-catenin. As a consequence, Arm/b-catenin protein
accumulates in the cytoplasm and can enter the nu-
cleus, where it acts as a co-activator of TCFs [11–16]
(Figure 1). Artificially preventing Arm from entering the
nucleus blocks Wnt signaling [17], while forcing it into
the nucleus can activate target genes [18–20]. There-
fore, the signaling activity of Arm/b-catenin is largely
controlled by the size of its nuclear pool, which de-
pends on the cytoplasmic levels of b-catenin as well
as on the import into and export out of the nucleus.
Nuclear Import and Export of Arm/b-catenin
The business of Arm/b-catenin’s import and export is
rather nebulous and somewhat controversial (Figure 2).
b-catenin appears to be imported into the nucleus in
a NLS- and importin/karyopherin-independent manner
by directly interacting with nuclear pore components
[21,22]. Addition of cytosol inhibits nuclear import of
b-catenin [21,22], indicative of the presence of cyto-
solic retention factors. Indeed, it was shown that
Axin could act as such a retention factor in Drosophila
[23]. By contrast, Pangolin (Pan), the Drosophila TCF
homologue, can function to keep Arm in the nucleus
[23]. However, a mutant form of Arm, that is defective
in binding Pan, still localizes to the nucleus [7,15]. It
has also been proposed that Lgs in cooperation with
Pygo serves as a nuclear anchor for Arm [20]. How-
ever, Arm still localizes to the nucleus in clones of cells
that are double-mutant for both axin and pygo, sug-
gesting that Pygo acts downstream of Arm nuclear
localization [24,25]. These findings show the difficulty
in designing experiments to clearly separate nuclear
import from retention of Arm/b-catenin. While the
Current Biology
R379Arm
Axin
APC
GSK-3β
Frizzled
TCF
Ar
ro
w
Wg
Arm
Arm
Arm
Arm
Lgs
Pygo
CTAA-BPs
E-cad
E-cad
Arm
Arm
α
α
Ar
ro
w
Dvl
A
r m
Ubiquitin 
mediated 
proteolysis
Axin
APC Arm
GSK-3β
P
Gro
Frizzled
TCF
Arm
E-cad
E-cad
Arm
Arm
α
α
CKI
CKI
CtBP
OFF ON
Current Biology
X
Dvl
Figure 1. Simplified overview of the Wg/
Wnt signaling pathway.
In the absence of the Wnt signal (‘OFF’
state, left cell), Armadillo (Arm)/b-catenin
protein levels are downregulated by
a complex containing Adenomatous poly-
posis coli (APC) protein, Axin, Casein
kinase I (CKI), and Glycogen synthase ki-
nase-3b (GSK-3b). In addition, the co-
repressors Groucho (Gro)/TLE and Car-
boxy-terminal binding protein (CtBP) are
bound to T-cell factor (TCF). The cell to
the right represents the ‘ON’ state of the
pathway. The Wg/Wnt ligand binds Friz-
zled and its co-receptor Arrow/LDL-
receptor-related protein (LRP). Axin is
bound by Dishevelled (Dvl) and Arrow,
thereby disrupting the ‘degradation com-
plex’. Arm/b-catenin accumulates in the
cytoplasm, enters the nucleus and dis-
places Gro from TCF. For transcription of
target genes Arm/b-catenin interacts
with Legless (Lgs), which binds Pygopus
(Pygo), and with carboxy-terminal activat-
ing arm binding proteins (CTAA-BPs), such as TATA-binding protein (TBP), Brahma/Brahma-related gene-1 (Brg-1), CREB-binding
protein (CBP)/p300, MED12, and Hyrax/Parafibromin. As part of adherens junctions, Arm/b-catenin binds the transmembrane protein
E-cadherin (E-cad) and the cytoplasmic protein a-catenin (a). Negatively acting components of the pathway are colored in red with
white letters, while positive components are shown in green with black letters.region comprising R10-C seems to be necessary and
sufficient for the nuclear import [26], different regions
of Arm/b-catenin that interact with binding partners
such as the above mentioned Pan and Lgs (together
with Pygo) could serve as anchor points contributing
to nuclear retention of Arm/b-catenin.
To further complicate matters, Arm also has an in-
trinsic nuclear export activity [21,22,27], which has
been shown to overlap with its ‘import region’ [26].
Moreover, Axin and APC may facilitate nuclear export
of Arm [28–31]. However, a recent paper that investi-
gated the nucleo-cytoplasmic shuttling of b-catenin
and its relation to TCF4, BCL9, APC, and Axin [32]
demonstrated that these proteins do not accelerate
the import/export rate of b-catenin. Rather, they influ-
ence the subcellular localization of b-catenin by retain-
ing it in the compartment in which they are localized. In
summary, the intracellular localization of Arm/b-cate-
nin represents a dynamic equilibrium of its intrinsic nu-
clear import and export activities as well as the avail-
ability and affinity of its binding partners.
Cancer and Arm/b-catenin
Mutations that constitutively stabilize Arm/b-catenin
can cause colorectal carcinomas and other forms of
cancer. One recent view described such cancers as
a ‘stem cell disease’ [33]. All cells in a normal colonic
crypt are thought to be derived from epithelial stem
cells sitting at the bottom of each crypt (Figure 3). They
are maintained as stem cells by a Wnt signaling system
[34]. Aberrant activation of the Wnt pathway leads to
an expansion of this stem cell population into upper re-
gions of the crypt. Instead of differentiating, such cells
replicate as if they were stem cells, resulting in over-
proliferation and the accumulation of mutations. Ulti-
mately, this results in polyps and adenomatous lesions
in the colon (Figure 3) [33,35]. The best-studied exam-
ple of such conditions, Familial Adenomatous Poly-
posis (FAP), is in most cases caused by truncationsin APC [36,37]. Truncated APC can no longer fulfill its
function in Arm/b-catenin degradation. As a conse-
quence, Arm/b-catenin accumulates and enters the
nucleus where it activates target genes implicated in
cell proliferation (e.g. c-Myc and gastrin [38,39]), inhi-
bition of apoptosis (e.g. survivin [40]), and tumor pro-
gression (e.g. Laminin g2 [41]) (Figure 3). How these
target genes exert their harmful effect in the various
steps towards tumorigenesis is currently not well un-
derstood. However, especially the Arm/b-catenin tar-
gets implicated in cell proliferation would fit into the
view of cancer as a ‘stem cell disease’.
Initial Steps of Target Gene Activation by Nuclear
Arm/b-catenin
How are nuclear Arm/b-catenin targets activated? In
the absence of Arm/b-catenin in the nucleus, Pan/
TCF is bound to Gro/TLE [42,43] and CtBP [44–47].
Gro/TLE family proteins are general long-range tran-
scriptional co-repressors, which have been shown to
interact with histone deacetylases [48]. Reduction of
Pan or Gro in the Drosophila embryo results in partial
suppression of armadillo and wingless mutant pheno-
types, whereas overexpression of Pan enhances the
phenotype of a weakwingless allele [43]. This suggests
that, in the absence of Wg signaling, a Pan–Gro com-
plex acts as a repressor of Wg targets in the embryo.
By contrast, loss of Pan in theDrosophilawing imaginal
disc results in a reduction of Wg target gene expres-
sion, but does not cause a derepression of these genes
outside the normal domain of expression. Loss of Gro
also does not result in derepression of Wg target genes
in the wing disc [49]. Thus, in this context Pangolin does
not appear to function by default as a repressor in the
absence of Wg signaling. Rather, it seems that the re-
pressor function of Pan can vary in different tissues.
Nuclear Arm/b-catenin binds to the amino terminus
of Pan/TCF and displaces Gro/TLE by binding to a sec-
ond, low-affinity binding site on TCF located in the
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Figure 2. Nucleo-cytoplasmic shuttling of
Arm/b-catenin.
Nuclear import (left) of Arm/b-catenin
works independently of the carrier pro-
teins Importin a/b and is mediated by di-
rect interaction of Arm/b-catenin with
components of the nuclear pore complex
(NPC). Arm/b-catenin’s release into the
nucleus does not depend on RanGTP. Nu-
clear import of Arm/b-catenin can be
counteracted by cytosolic retention fac-
tors such as Axin and E-cadherin. Nuclear
export (right) of Arm/b-catenin works in an
Exportin/RanGTP-independent manner,
and no Ran GTPase activating protein
(RanGAP) is required to release Arm/b-
catenin on the cytosolic side. Proteins
like APC and Axin, which can bind Arm
and shuttle between the nucleus and the
cytoplasm (Ran dependent), may facilitate
nuclear export of Arm, whereas nuclear
proteins that interact with Arm, like TCFs
or Lgs (together with Pygo), might serve
as nuclear retention factors and decrease
the nuclear export rate of Arm.carboxy-terminal half of the protein, which overlaps
with the Gro/TLE binding site [50]. Interestingly, nei-
ther the amino nor the carboxyl terminus of b-catenin
are necessary for this displacement, suggesting that
it is — like TCF binding — accomplished by the central
Arm repeat domain. CtBP proteins are general, short-
range transcriptional co-repressors that interact with
histone deacetylases [51]. TCF3 and TCF4 have been
shown to bind CtBP in vitro and in vivo [44–47]. The
binding of CtBP represses TCF3- and TCF4-mediated
transcription and this repression depends on histone
deacetylase activity [44–46]. To date, it is not clear how
Wnt signaling overcomes the repressor effect of CtBP
on TCF3 and TCF4 and whether b-catenin plays an
active role in this process. After the release of the
Gro/TLE and CtBP repressor systems from Pan/TCF,
nuclear Arm/b-catenin can fully develop its transcrip-
tional activator potential.
In the nucleus, Arm/b-catenin binds the DNA binding
protein Pan/TCF/Lymphoid enhancer factor (LEF)
through R3-10 [11–16,52] (Figure 4). In addition to the
Pan/TCF/LEF binding domain, there are two other
domains which are important for Wg/Wnt signaling,
namely R1 and R11-C [7]. It was shown recently that
R1–4 are necessary and sufficient for Lgs binding
[8,53–55], and that R11-C are important for the binding
of proteins such as TBP, Brahma/Brg-1, CBP/p300,
MED12, and Hyrax/Parafibromin [56–61]. Mutations
in, or deletions of these two domains result in reduced
signaling activity of Arm/b-catenin [7,8,15,62,63]. In
addition, both domains have been shown to exhibit
signaling activity on their own [15,18,54]. From here
on we refer to these two activating arms of Arm/b-cat-
enin as ‘NTAA’ and ‘CTAA’ for amino-terminal activat-
ing arm (R1-5) and carboxy-terminal activating arm
(R10-C), respectively.
Co-Factors for Nuclear Arm/b-catenin
CTAA Interaction Partners
Arm/b-catenin has several partners that bind the CTAA
and contribute to transcriptional activation, five ofwhich are briefly discussed here. One of these proteins
is TBP, which has been shown to bind b-catenin at
R12-C [57]. Notably, there are two more domains in
b-catenin that bind TBP, namely the amino terminus
and R2-4. So far, further experimental data for the
functional significance of the b-catenin–TBP interac-
tion are lacking.
Furthermore, Brg-1, a component of mammalian
SWI/SNF and Rsc chromatin remodeling complexes,
has been shown to bind Arm/b-catenin through R7-
12. Overexpression of Brg-1 promotes transcriptional
activation of TCF-responsive reporter genes. In Dro-
sophila, the SWI/SNF component Brahma genetically
interacts with Arm [56].
In addition, p300 and the closely related CBP are
transcriptional co-activators that link proteins to the
basal transcription machinery or alter chromatin struc-
ture through their intrinsic or associated histone ace-
tyltransferase activities. p300 and CBP bind R10-C
of b-catenin and stimulate transcriptional activity
[58,59]. Interestingly, although the co-activators p300
and CBP are closely related, they do not always exert
the same effects on promoters; for instance, they have
opposite effects on the b-catenin-mediated expres-
sion of the survivin gene. The small molecule ICG-
001, which specifically blocks the CBP–b-catenin in-
teraction, but not the p300–b-catenin interaction,
inhibits survivin gene expression. In the absence of
ICG-001, CBP is associated with the survivin pro-
moter. In the presence of ICG-001 there is less CBP
at the promoter but more p300 instead, which in turn
recruits repressive elements and results in a reduction
of survivin transcription [64].
MED12, a component of the Mediator complex, has
been found to interact with b-catenin at R12-C [61].
The Mediator (MED) complex, first discovered in yeast,
links transcriptional regulators to RNA polymerase II
(Pol II) and general transcription factors [65–67]. Mean-
while, counterparts for nearly all yeast MED compo-
nents have been discovered in mammals [68–70].
RNAi-mediated knock-down of MED12 as well as
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main of MED12 in HeLa cells impair b-catenin-depen-
dent transactivation in response to Wnt signaling [61].
Lastly, it has recently been shown that the Drosoph-
ila and human homologs of yeast Cdc73p (Hyrax and
Parafibromin, respectively) are involved in Wg/Wnt
signaling. Cdc73p is a component of the Polymer-
ase-associated factor 1 (PAF1) complex, a conserved
Pol II interacting complex, which has been implicated
in the regulation of transcriptional initiation and elon-
gation [71]. Hyrax and Parafibromin bind to R12-C of
Arm and b-catenin, respectively. Overexpression of
these proteins results in an increase of Wg/Wnt path-
way activity, while experimental reduction of their
levels has the opposite effect [60]. Besides the five
co-activator partners described above that bind di-
rectly to the CTAA of b-catenin, it was recently shown
that the TRRAP/TIP60, the ISW1, and the MLL1/MLL2
SET1-type complexes also selectively associate with
the CTAA [72]. All three of these complexes are in-
volved in histone modification and chromatin remodel-
ing. However, it has not been resolved yet whether
they interact directly with b-catenin.
NTAA Interaction Partners
Pontin/Tip49 and Reptin/Tip48 are two highly homolo-
gous proteins, which can form homo- and hetero-
dimers. They have been shown to bind to b-catenin
R2-5 and antagonistically affect b-catenin output.
Reptin inhibits transcriptional activation of reporter
genes, whereas Pontin enhances it. In Drosophila, mu-
tations in the pontin and reptin genes exhibited oppo-
site dominant effects on wing phenotypes in a genetic
background sensitized for Arm signaling [73,74]. Also
in zebrafish Pontin and Reptin function antagonisti-
cally: the liebeskummer (lik) mutation encodes an
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Figure 3. Wnt signaling in colorectal cancer (CRC).
Schematic depiction of a colonic crypt, the left side is wild type
and the right side shows the diseased condition. A Wnt signal at
the bottom of the crypt blocks b-catenin degradation, thereby
activating target genes that maintain the cells in a proliferating
state (green). Halfway up the crypts, b-catenin is downregu-
lated and the progenitor crypt cells start to differentiate (blue).
Mutations in either APC or b-catenin result in cells (red) consti-
tutively expressing Wnt target genes, thus preventing such cells
from differentiating. The cells maintain their progenitor state
and continuously proliferate. Adapted from [90].activated Reptin protein and promotes cardiac hyper-
plasia. This phenotype is enhanced by reduction of
b-catenin or Pontin expression in a heterozygous lik
mutant [75]. In a chromatin immunoprecipitation ex-
periment, Pontin, Tip60, and TRRAP interacted with
the promoter of a TCF-dependent gene, ITF-2 (immu-
noglobulin transcription factor-2). Overexpression of
an inactive form of Pontin resulted in decreased acet-
ylation of histones and reduction of ITF-2 expression
[76]. The domains of b-catenin to which Pontin, Reptin,
and Lgs bind are overlapping (R2-5 and R1-4). How-
ever, it is presently unknown whether they bind simul-
taneously or in a competitive manner.
Lgs and Pygo were discovered in genetic screens for
modifiers of the Drosophila Wg pathway [24,25,53,77].
Loss of lgs or pygo function results in a severe reduc-
tion of pathway output. Arm/b-catenin binds Lgs
through R1-4 and the acidic amino acids D162 and
D164 play a key role in this interaction [8,53]. Replacing
wild-type Arm with Arm-D164A (which cannot bind
Lgs) causes phenotypes that are very similar to those
of lgsnull mutants [8]. The predominantly nuclear local-
ization of Lgs depends on the presence of Pygo [20]. It
has been proposed that Lgs and Pygo function mainly
to enhance the nuclear levels of Arm [20,78]. This no-
tion was based on an experiment in which the cuticular
phenotype of lgs and pygo mutant embryos was ame-
liorated by overexpressing a form of Arm with a nuclear
localization signal. This experiment indeed showed
that high amounts of nuclear Arm can activate Pan
targets in the absence of Lgs or Pygo, most likely by
displacing Gro/TLE from Pan and by recruiting the
activators described above via the CTAA. However, in
a different set of experiments it was shown that
a DNA-tethered and constitutively nuclear form of
Arm/b-catenin can only very poorly activate reporter
gene expression if it carries the D164A mutation, sug-
gesting that Lgs/BCL9 binding critically contributes
to Arm/b-catenin’s activator capacity [54,79]. Further-
more, constitutive nuclear targeting of Lgs does not
bypass the requirement for Pygo in Wg signaling, indi-
cating that Pygo must provide a function beyond
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Figure 4. Schematic overview of what binds where on Arm/
b-catenin.
The Arm repeats are numbered 1–12. Blue lines show the amino-
terminal activating arm (NTAA) and the carboxy-terminal acti-
vating arm (CTAA). The black lines represent binding domains
of Arm/b-catenin interacting proteins. APC (Adenomatous poly-
posis coli), a (a-catenin), TCF (T-cell factor), CBP (CREB-bind-
ing protein, CREB (cAMP response-element binding protein))/
p300, Lgs (Legless), Brg-1 (Brahma-related gene-1), TBP
(TATA-binding protein), MED12 (Mediator subunit 12).
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Figure 5. Model of nuclear Arm/b-cate-
nin’s control over transcription.
Nuclear Arm/b-catenin is recruited to
Wingless target genes by high mobility
group (HMG) transcription factors of the
TCF/LEF family, which all have an Arma-
dillo-binding domain (ABD) at their very
amino termini. Arm acts through two acti-
vating arms. The amino-terminal activat-
ing arm acts mainly through the co-activa-
tor Pygopus (Pygo), which is recruited to
Arm via the adaptor protein Legless (Lgs).
Lgs binds to Arm with its homology do-
main 2 (HD2) and to the plant homology
domain (PHD) of Pygo with its homology
domain 1 (HD1). For the co-activator func-
tion of Pygo, its amino-terminal homology
domain (NHD) is essential. The carboxy-
terminal activating arm can interact with
protein complexes exhibiting histone ace-
tyltransferase (HAT) or chromatin remodeling (SWI/SNF complex) activities. It further interacts with components that can recruit his-
tone methyltransferases (e.g. MLL/SET1) or play important roles in transcription initiation and elongation (MED complex, PAF1 com-
plex). Sequential or random recruitment of these factors and complexes, step-by-step, results in a more accessible chromatin structure
and finally leads to transcription of the target gene.ensuring the availability of Lgs and Arm/b-catenin in
the nucleus [79]. These findings, therefore, argue that
Arm depends on Lgs and Pygo primarily for its tran-
scriptional function rather than for its nuclear import
or retention. In addition to the Arm/b-catenin CTAA,
there appears to be a Lgs-Pygo-dependent output
from the NTAA important for Arm activity. In this
NTAA function, Lgs seems to serve as an adaptor pro-
tein linking Pygo to Arm/b-catenin [53], whereas the
amino-terminal homology domain of Pygo is a critical
mediator of this function, as it cannot be bypassed [54].
Target Gene Activation by Nuclear Arm/b-catenin
Transcriptional activation of target genes requires the
recruitment of ATP-dependent chromatin remodeling
enzymes and histone acetyltransferase complexes to
their promoters to ‘prepare’ the chromatin. There ap-
pears to be no obligate order of function for these
complexes [80]. After chromatin preparation, RNA
Pol II is recruited and transcription initiated. In the
case of the LEF–b-catenin complex it has been shown
that R11-C of b-catenin is necessary for chromatin re-
modeling in vitro [81]. This region of b-catenin partially
overlaps with binding sites for Brg-1 (R7-12) and p300/
CBP (R10-C). These two proteins could be involved in
the preparation of chromatin at Wg/Wnt target genes.
In addition, components of the MLL/SET1-type chro-
matin modifying complexes associate with this do-
main of b-catenin and augment histone methyltrans-
ferase activity and H3K4-tri-methylation at the Wnt
target gene c-Myc [72].
The identification of MED12 as a b-catenin binding
protein [61] provides a possible link between b-catenin
and Pol II. The MED complex can associate with Pol II
to generate a stable complex sometimes called the
Pol II holoenzyme [82,83]. Yet, a second possible link
between b-catenin and Pol II came forward with the
discovery of Hyrax/Parafibromin as an Arm/b-catenin
interaction partner, which interestingly also binds to
the CTAA and, thus, overlaps with the Brahma/Brg-1,
CBP/p300, and MED12 binding sites. The PAF1 com-
plex, which contains Parafibromin, has been foundto associate with the nonphosphorylated and Ser2
and Ser5 phosphorylated forms of the large subunit of
Pol II [84]. Another study [85] describes the tumor sup-
pressor Parafibromin as a PAF1 complex- and Pol II-
bound protein acting in transcription elongation and
RNA processing. As the PAF1 complex has been
shown to physically interact with the SET1 complex
[86], an attractive idea would describe the role of
Hyrax/Parafabromin as a recruiting module not only
for Pol II, but also for the MLL/SET1-type complexes.
Mosimann et al. [60] showed that there might be
a Hyrax/Parafibromin-related crosstalk between the
CTAA of b-catenin and Pygo. As described above,
overexpression of Parafibromin leads to an increase
in Wnt-reporter gene activity in tissue culture cells.
However, this increase depends on Pygo as it can be
abrogated by the siRNA-mediated reduction of Pygo.
In other words, the activating function of Hyrax/Parafi-
bromin in the Wg/Wnt pathway seems to depend on
the recruitment of Pygo to b-catenin. These findings
might implicate Pygo in stabilizing or exchanging
trans-activating complexes that bind the Arm/b-cate-
nin CTAA. Taken together, a model can be composed
(Figure 5) according to which Wg/Wnt target gene ac-
tivation is a concerted, Pygo-assisted process, which
dynamically coordinates the sequential action of tran-
scriptional modulators at the central scaffold protein
Arm/b-catenin.
De-activation of Target Genes and Nuclear
Arm/b-catenin
Although not much is currently known about how Arm/
b-catenin-regulated genes are turned off, three pro-
cesses are likely to be important: disassembly of the
Arm/b-catenin enhancer complex, reversion of the ‘ac-
tivating’ histone modifications and nuclear export and
degradation of Arm/b-catenin. Recent work by Sierra
et al. [72] raises the possibility that APC may be pivotal
for all three of these processes. The association of
full-length APC with the Wnt-dependent enhancer
of the c-Myc gene correlates with the disassembly of
the b-catenin enhancer complex, resulting in a rapid
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posed that full-length APC may recruit CtBP and the b-
Transducin repeats-containing protein (b-TrCP) to the
c-Myc enhancer. APC has previously been shown to
directly interact with CtBP, both in vivo and in vitro
[47]. Lysine-specific demethylase 1 (LSD1), a compo-
nent of CtBP complexes, has been implicated in re-
verting H3K4 mono- and di-methylation in vitro [87].
To our knowledge, factors that catalyze the removal
of a methyl group from tri-methylated lysines (e.g. tri-
methylated H3K4) have not yet been described. APC
may further bind to Arm/b-catenin and remove it
from TCF/LEF, which in turn is then free to recruit
Gro/TLE-1 and histone deacetylase complexes, while
APC might facilitate nuclear export of Arm/b-catenin
and promote its cytosolic degradation [88,89].
This scenario, in which a nuclear pool of APC coun-
teracts Wnt signaling at multiple levels, still lacks de-
finitive experimental confirmation and also raises
some questions. For example, how is APC recruited
to enhancers of TCF/LEF target genes, when Arm/b-
catenin cannot interact simultaneously with TCF/LEF
and APC due to overlapping binding sites? Does
APC perhaps interact with other subunits of the Arm/
b-catenin enhancer complex? Undoubtedly however,
the mechanism by which APC counteracts transcrip-
tion of Wg/Wnt targets will be central to understanding
how Arm and b-catenin undergo nuclear disarmament.
The Future of Nuclear Arm/b-catenin
Lgs and Pygo have so far mainly been analyzed in Dro-
sophila. While those studies clearly show that both
proteins are very important for Wg signaling, little is
known about their significance in the vertebrate path-
way. It was shown in zebrafish that B9L (BCL9-like or
BCL9-2) is required for the induction of the T-box tran-
scription factor tbx6, a Wnt8 target gene [55]. It will be
very interesting to see what the phenotypes of mouse
lgs and pygo knock-outs are. Will the NTAA of b-cate-
nin play an equally essential role for Wnt pathway out-
put as the CTAA? Or are there species- or gene-spe-
cific differences regarding their requirements? For the
CTAA, future studies will shed more light on the car-
boxy-terminal interactors. Is their order of action con-
stant and critical, or can they transcriptionally prepare
and activate Wnt targets by variable means? What
about genes repressed by Wnt signaling? Is Arm/b-
catenin also able to function as a Wnt signal-dependent
repressor of gene transcription, or are Wnt-repressed
genes only indirectly regulated by nuclear Arm/b-cate-
nin? Clearly, resolving the unclear issues of nuclear
Arm/b-catenin will necessitate efforts in different
fields. The reward may not only be to understand, but
also to interfere with, aberrant pathway activity.
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